|
Stories from the dialysis comunity across the globe.
|
|
|
|
Biocon's Nine-Month Revenues Driven by Growth in Branded Formulations ... - Moneylife Personal Finance site and magazine |
 |
 |
Moneylife Personal Finance site and magazine
Biocon is present in the chronic segment with over 70 brands spread across six verticals namely, Diabetology, Oncotherapeutics, Nephrology, Cardiology, Immunotherapy and Comprehensive Care. Outpacing the market, this vertical has posted a combined YoY
|
|
Conn. doctor grabs Cundiff's errant kick - WTNH |
|
|
WTNH
Dr. Oder, a nephrologist, says he brought the ball to work with him the next day and made his dialysis patients happy at a time when their day wasn't so bright. Dr. Oder is a former youth football running back.
The secret behind New England Patriots quarterback Tom Brady is a QB guru, Tom
|
|
|
Osteoporosis medications in patients with kidney disease - Clinical Advisor |
|
|
Clinical Advisor
To minimize the risk of chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD), such osteoporosis medications as alendronate (Fosamax) and ibandronate (Boniva) are contraindicated in individuals whose glomerular filtration rate
|
|
Tumor Necrosis Factors Predict Kidney Disease in Diabetes - MedPage Today |
|
|
MedPage Today
The cumulative incidence of end-stage renal disease (ESRD) among those with type 2 diabetes who had the highest quartile of TNFR1 at baseline was 54% at 12 years, compared with only 3% for the other quartiles (P< 0.001), reported Andrzej S. Krolewski,
|
|
|
|
|
<< Start < Prev 951 952 953 954 955 956 957 958 959 960 Next > End >>
|
|
Page 951 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
